TOI & CareMore care model showcases better cancer care at lower cost
Category: #research  By Nikita Chaurasia  Date: 2019-09-09
  • share
  • Twitter
  • Facebook
  • LinkedIn

TOI & CareMore care model showcases better cancer care at lower cost
  • The study registered CareMore patients that were newly diagnosed with hematologic and solid malignancies from November 2016 to September 2018.
     
  • The cancer care model which is value-based used LHWs, they are non-physician community members who have obtained specialized training to help patient navigation and care.

The Oncology Institute, (TOI) and Stanford University’s School of Medicine as well as CareMore Health together announced the outcome from a study; improving community capacity to provide value-based cancer care during the end-of-life.

The study examined the effect of interference of having lay health workers, LHWs, for cancer care during the end-of-life. Precisely, the study evaluated the use of healthcare at life’s last month and its effect on financial burden and quality care for patients.

The study registered CareMore patients that were newly diagnosed with hematologic and solid malignancies from November 2016 to September 2018. The study matched results to a controlled set of all patients detected with cancer in the year earlier to intervention.

The cancer care model which is value-based used LHWs, they are non-physician community members obtained specialized training to help in patient navigation and care. The study found no difference in living between the control groups of patients, while the patients getting the value-based care witnessed greater quality along with cancer care at end-of-life.

The latter group of patients had 40% lesser inpatient admissions, 75% lesser visits to emergency department at the last month of their life, increased hospice use of 45% was witnessed, 40% fewer acute care service deaths and median totalized healthcare costs reduced by 25% from diagnosis till death.

Assistant prof. of medicine at Stanford University School for Medicine and the head investigator of the study, Manali Patel, MD, MPH stated that due to this trial the care model which is value-based developed by the group at Stanford and applied by the Oncology Institute is connected with significant enhancements in patient care at the life’s end.

 

Source credit: https://www.businesswire.com/news/home/20190907005023/en/Study-Demonstrates-Significantly-Quality-Cancer-Care-Costs

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Google to settles fiscal fraud probe with French authorities
Google to settles fiscal fraud probe with French authorities
By Nikita Chaurasia

The company has decided to pay 1 billion euros to the French regulators, considerably less than the 1.6 billion euros that it had to pay for the raid in 2016. Google LLC, a multinational tech company that offers internet-related services, has decid...

TrakCel & McKesson partner to help commercialize gene & cell therapy
TrakCel & McKesson partner to help commercialize gene & cell therapy
By Nikita Chaurasia

The combination of these two product suites is designed specifically for the growing number of developers that are nearing the commercial launch of gene and cell therapies. The integrated platform allows the product scale-up towards market deliver...

Seoul Semiconductor files patent breach claim against Conrad
Seoul Semiconductor files patent breach claim against Conrad
By Nikita Chaurasia

The South Korean company sued a European electronic products retailer on account of the violation of patented backlight unit LEDs.   The lawsuit filed is aimed to secure the second-generation LED technology. A South Korea based LED manufac...